GNRC Generac Holdings Inc.

You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...

A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...

The Specialty Food Scene Heats Up Today’s world doesn’t rest when it comes to innovation, and the same goes for the tantalizing realm of specialty foods. Hot off the press, the Specialty Food Association (SFA) just rolled out the red carpet for its 75 finalists in the 2027 sofi™ Awards. These are the future taste shapers set to take center stage at the Winter...

AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...

The Clock is Ticking for AVEX Investors News flash, folks: If you bought into AEVEX Corp. (NYSE: AVEX) between mid-April and early June this year, you might have a legal gold mine on your hands—or at least a shot to join a class action that could knock some dollars back into your pocket. Mark it on your calendar—October 20, 2026, is the last call to toss your hat in...

Welcoming a Highly Skilled Oncologist to Fort Myers There's an old saying in the world of investing: follow the expertise. And when it comes to healthcare, especially cancer treatment, expertise can make a world of difference. Florida Cancer Specialists & Research Institute (FCS) is throwing its hat in the ring with authority, as they welcome Dr. Kelly Elleson, a surgical...

Breaking Ground in Cancer Treatment Trials I've seen some thrilling breakthroughs in my time following the pharmaceutical industry, but what Kansai Medical University and Daiichi Sankyo are doing elevates the game. They're rolling out the first patient dose of DS1025 in Osaka, Japan—a move that marks the onset of a global Phase 1 clinical trial. This is no ordinary...

Collagen Solutions Front and Center First up, a little chat about collagen might be in order. For folks not tied into the science side, it sounds like a trendy wellness potion. But here comes GELITA at SupplySide Global 2026, showing it's the real McCoy. Nestled in Booth #4565, they're laying out a spread of next-gen collagen innovations aimed at everything from wound...

A Peek into the Sale: What's on the Block? Get that coffee brewing and settle in, because we've got to unpack some interesting stuff happening with Chicago Scenic Studios. This isn't just any Craigslist decampment—Integra Asset Solutions is rolling out an online auction come October 27 that’ll have equipment-savvy investors’ ears perking up like they just snagged a...

Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....

First Trust Mortgage Income Fund's Monthly Distribution Announcement First Trust Mortgage Income Fund (NYSE: FMY) has declared its upcoming monthly common share distribution, marking an important date for its shareholders. The distribution set at $0.075 per share is payable soon, showing the Fund's commitment to providing consistent returns. Details About the Distribution...

Revolutionizing Cancer Treatment Through Innovation Akeso Inc. has announced its annual results for 2024, showcasing major achievements in biotechnology innovation. The company has focused on developing cutting-edge therapies, particularly in bispecific antibodies, aimed at transforming the treatment landscape for various cancers. Key Accolades and Advancements Key...

Rona Therapeutics Makes Significant Strides in Hypertension Treatment Rona Therapeutics, a biotechnology leader in RNA-targeted therapies, has achieved an impressive milestone with the approval of its Investigational New Drug (IND) application for RN1871 by China's National Medical Products Administration (NMPA). This innovative small interfering RNA (siRNA) drug is...

Understanding Fleet Management Market Evolution The global fleet management market is poised for significant growth, expected to expand by USD 52.23 billion between 2025 and 2029. This growth is primarily fueled by the surge in e-commerce and the pressing need for last-mile delivery solutions. As industries continue to evolve, the integration of technology is transforming...

Understanding the Global Anisole Market Trends The global anisole market has been on a robust growth trajectory. Valued at approximately US$ 98.78 million as of recent estimates, it is poised to reach a remarkable US$ 165.48 million by 2033, with a compound annual growth rate (CAGR) of 5.9% from 2025 onwards. This upward trend indicates a significant demand for anisole...